Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today announced appointment of Dr. Caroline MacCallum and Jacques Dessureault to its board of directors. Per the update, Dr. MacCallum is one of the world’s most prominent experts in cannabinoid-based medicine. At the University of British Columbia, she is an internist, complex pain and cannabinoid clinician, researcher and clinical instructor in the Department of Medicine, an adjunct professor in the Faculty of Pharmaceutical Sciences Program and an associate member of the Department of Palliative Care. Dr. MacCallum is also Greenleaf Medical Clinic’s medical director, where she has assessed and developed cannabinoid treatment plans for more than 3,000 patients across Canada. Jacques Dessureault has an extensive pharmaceutical career with significant experience in life sciences, over-the-counter, natural health, and technology industries. He has held multiple leadership positions, including serving in an international role with Novartis as its global marketing division head based in Basel, Switzerland, and domestic senior executive roles as president and general manager of Valeant Pharmaceutical Inc., vice president at Bristol Myer-Squibb and business unit head and general manager at Novartis Canada. At Valeant Pharmaceuticals, Dessureault led all Canadian commercial units including research and development and international manufacturing and technical operations. In addition, he held responsibilities for government relations and business acquisitions, integrations and divestments.
“We are incredibly fortunate to add Dr. MacCallum and Jacques Dessureault to our Board of Directors at such a pivotal time, as we approach production ramp-up and our first commercial sales,” TGOD Chairman of the Board Jeff Scott stated in the news release. “The TGOD Board now consists of independent directors with the exception of our CEO. Both new additions possess valuable skills and extensive experience that will greatly benefit TGOD moving forward.”
To view the full press release, visit http://cnw.fm/MH4Ew
About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. is a premium global organic cannabis company, with operations focused on legal medical cannabis markets in Canada, Europe and Latin America and the legal Canadian adult-use market. The company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 170,000 kg and is building 1,382,000 sq. ft. of cultivation facilities across Ontario, Quebec and Jamaica. In addition, TGOD has raised approximately C$460 million and has over 20,000 shareholders. TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively. For more information, visit the company’s website at www.TGOD.ca.
More from CannabisNewsBreaks
About HempWire
HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.
To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.hempwire.com
Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/
HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net
InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company developing small molecule drug candidates for diseases with…
CannabisNewsWire (CNW), a trusted communications platform within the cannabis sector and a part of InvestorBrandNetwork…
Turning Point Brands (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, recently…
WEED Inc. (OTCQB: BUDZ), a global cannabis and hemp bioresearch company based in the U.S.,…
Flora (NASDAQ: FLGC) has closed a registered direct offering to institutional investors for the aggregate…
Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced its plans to host a Spaces call…